Proline

Proline

SCHEMBL5201122

O=C(O)C1CCCN1c1ccc([N+](=O)[O-])cc1.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Proline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 5/20 0.46
MCHR1 Q99705 3/20 0.41
TDP1 Q9NUW8 1/20 0.40
ADRB1 P08588 1/20 0.39
SIRT6 Q8N6T7 1/20 0.39
DPP4 P27487 2/20 0.39
SLC6A3 Q01959 1/20 0.39
NPBWR1 P48145 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38
POLB P06746 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proline SCHEMBL5201120 1.00 SMN1; SMN2 (0.46) SMN1; SMN2MAPTMCHR1TDP1ADRB1
SCHEMBL3552397 0.88 MAPT (0.56) SMN1; SMN2MAPTMCHR1TDP1NPBWR1
SCHEMBL9660476 0.88 MAPT (0.56) SMN1; SMN2MAPTMCHR1TDP1NPBWR1
SCHEMBL3552399 0.88 MAPT (0.56) SMN1; SMN2MAPTMCHR1TDP1NPBWR1
SCHEMBL5201129 0.84 MAPT (0.41) SMN1; SMN2MAPTMCHR1ADRB1SIRT6
Nitrobenzene SCHEMBL27746452 0.79 LMNA (0.48) MAPTTDP1DPP4SLC6A3ALDH1A1
4-Nitroaniline SCHEMBL3413641 0.78 ALDH1A1 (0.50) SMN1; SMN2MAPTTDP1DPP4SLC6A3
SCHEMBL28149835 0.74 MAPT (0.44) SMN1; SMN2MAPTMCHR1TDP1NPBWR1
SCHEMBL3554528 0.73 MAPT (0.48) SMN1; SMN2MAPTMCHR1SIRT6NPBWR1
SCHEMBL3885054 0.73 MAPT (0.61) SMN1; SMN2MAPTMCHR1SLC6A3NPBWR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1748999-A1 IMIDAZOLO-5-YL-2-ANILINOPYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION AstraZeneca AB (SE) 2007-02-07 EP disclosed
WO-2005075461-A1 IMIDAZOLO-5-YL-2-ANILINOPYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION ASTRAZENECA AB (SE) 2005-08-18 WO disclosed